Genome-wide CRISPR screens identify PARP inhibitor sensitivity and resistance in prostate cancer
Prostate cancer tumors harboring BRCA1/2 mutations are exceptionally sensitive to PARP inhibitors, while genomic alterations in other DNA damage response (DDR) genes are less responsive. To identify previously unknown genes ...
Apr 4, 2023
0
4